Aclaris Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $18.2M | $243.5M | $20.2M |
| FY2018 | $60.4M | $275.6M | $57.0M |
| FY2019 | $28.4M | $98.3M | $34.2M |
| FY2020 | $33.1M | $70.8M | $22.1M |
| FY2021 | $53.9M | $251.2M | $27.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $18.2M | $243.5M | $20.2M |
| FY2018 | $60.4M | $275.6M | $57.0M |
| FY2019 | $28.4M | $98.3M | $34.2M |
| FY2020 | $33.1M | $70.8M | $22.1M |
| FY2021 | $53.9M | $251.2M | $27.3M |